Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells

Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
Nature Biotechnology (Impact Factor: 41.51). 06/2013; 31(7). DOI: 10.1038/nbt.2620
Source: PubMed


The interaction between the HSP90 chaperone and its client kinases is sensitive to the conformational status of the kinase, and stabilization of the kinase fold by small molecules strongly decreases chaperone interaction. Here we exploit this observation and assay small-molecule binding to kinases in living cells, using chaperones as 'thermodynamic sensors'. The method allows determination of target specificities of both ATP-competitive and allosteric inhibitors in the kinases' native cellular context in high throughput. We profile target specificities of 30 diverse kinase inhibitors against >300 kinases. Demonstrating the value of the assay, we identify ETV6-NTRK3 as a target of the FDA-approved drug crizotinib (Xalkori). Crizotinib inhibits proliferation of ETV6-NTRK3-dependent tumor cells with nanomolar potency and induces the regression of established tumor xenografts in mice. Finally, we show that our approach is applicable to other chaperone and target classes by assaying HSP70/steroid hormone receptor and CDC37/kinase interactions, suggesting that chaperone interactions will have broad application in detecting drug-target interactions in vivo.

Download full-text


Available from: Nathanael Gray, Aug 08, 2014
  • Source
    • "Cheap, reliable structures and materials capable to detect, store, and controllably release hydrogen are critical elements for many applications ranging from energy conversion devices [1] [2] to biotechnology [3], catalysis [4], medicine [5], and hydrogen leak detection [6]. Such materials and structures should satisfy various and sometimes conflicting requirements. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We report on the fabrication of bi-dimensional alumina/palladium nanowire nanoarchitectures for hydrogen detection, storage and controlled release. This nanostructured material was fabricated by growing the palladium nanowires directly in the nanosized channels of nanoporous alumina membrane followed by atmospheric-plasma jet treatment to fabricate the interconnected surface structure mostly suitable for hydrogenrelated applications such as controlled release and sensing. Several interesting properties are demonstrated, including high sensitivity levels (up to 0.1% of H2 in air) and short response times. Large resistance response reaching 100% for 0.5% of H2 in air makes it possible to use the fabricated sensors without complex and expensive amplifying circuits. Copyright © 2015, Hydrogen Energy Publications, LLC. Published by Elsevier Ltd. All rights reserved.
    Full-text · Article · May 2015 · International Journal of Hydrogen Energy
  • Source
    • "Importantly, many other mutated oncogenic kinases, including other SRC family kinases, BCR-ABL (a fusion protein associated with chronic myelogenous leukemia) and BRAF (a serine/threonine kinase that is frequently mutated in melanomas), display this same general problem in protein folding and require similar assistance from the HSP90-based chaperone machinery to exert their malignant phenotypes (for a recent review, see Trepel et al., 2010). The differential requirements that the mutated oncogenic kinases display for HSP90, compared with their normal cellular counterparts, have led to extensive efforts to understand HSP90 function in the treatment of cancers (Whitesell et al., 2012; Taipale et al., 2013). HSP90 is only one of the protein homeostatic mechanisms that contribute to cancer. "
    [Show abstract] [Hide abstract]
    ABSTRACT: For a protein to function appropriately, it must first achieve its proper conformation and location within the crowded environment inside the cell. Multiple chaperone systems are required to fold proteins correctly. In addition, degradation pathways participate by destroying improperly folded proteins. The intricacy of this multisystem process provides many opportunities for error. Furthermore, mutations cause misfolded, nonfunctional forms of proteins to accumulate. As a result, many pathological conditions are fundamentally rooted in the protein-folding problem that all cells must solve to maintain their function and integrity. Here, to illustrate the breadth of this phenomenon, we describe five examples of protein-misfolding events that can lead to disease: improper degradation, mislocalization, dominant-negative mutations, structural alterations that establish novel toxic functions, and amyloid accumulation. In each case, we will highlight current therapeutic options for battling such diseases.
    Full-text · Article · Jan 2014 · Disease Models and Mechanisms
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inhibition of heat shock protein 90 (Hsp90) abrogates signaling of multiple aberrantly activated oncogenic proteins simultaneously, particularly mutated or amplified kinases, which provides an attractive approach for cancer treatment. Here, we described that FS-93, a potent Hsp90 inhibitor, impacted the survival of several types of oncogene addicted cancer cells through inducing G2/M arrest and apoptosis. Mechanistically, FS-93 treatment triggered the degradation of key client proteins such as HER2, EML4-ALK and c-Met and thereby abolished their downstream signaling pathways. Importantly, FS-93 alone circumvented MET amplification contributed acquired resistance to EGFR inhibition. Our study implicates that targeting Hsp90 is a promising alternative therapeutic tactic in oncogene addicted and derived resistant cancer cells.
    Full-text · Article · Jun 2015
Show more